Your browser is no longer supported. Please, upgrade your browser.
PDLI PDL BioPharma, Inc. daily Stock Chart
PDL BioPharma, Inc.
Index- P/E- EPS (ttm)-0.73 Insider Own0.90% Shs Outstand115.91M Perf Week7.56%
Market Cap294.76M Forward P/E- EPS next Y-0.09 Insider Trans-23.74% Shs Float110.26M Perf Month14.80%
Income-85.60M PEG- EPS next Q0.00 Inst Own87.50% Short Float10.00% Perf Quarter-15.93%
Sales51.80M P/S5.69 EPS this Y-25.60% Inst Trans2.26% Short Ratio10.53 Perf Half Y-15.41%
Book/sh3.63 P/B0.71 EPS next Y83.30% ROA- Target Price2.50 Perf Year10.70%
Cash/sh0.92 P/C2.80 EPS next 5Y14.00% ROE- 52W Range1.90 - 3.50 Perf YTD2.68%
Dividend- P/FCF- EPS past 5Y-18.30% ROI-17.00% 52W High-26.83% Beta1.17
Dividend %- Quick Ratio13.30 Sales past 5Y-37.70% Gross Margin2.70% 52W Low34.90% ATR0.09
Employees75 Current Ratio13.70 Sales Q/Q-30.70% Oper. Margin- RSI (14)59.95 Volatility3.52% 3.78%
OptionableYes Debt/Eq0.03 EPS Q/Q-62.00% Profit Margin- Rel Volume1.57 Prev Close2.50
ShortableYes LT Debt/Eq0.03 EarningsNov 09 AMC Payout- Avg Volume1.05M Price2.56
Recom- SMA2011.18% SMA503.28% SMA200-3.95% Volume1,645,951 Change2.40%
Dec-22-16Resumed Piper Jaffray Overweight
Feb-23-16Reiterated RBC Capital Mkts Sector Perform $5 → $4
Feb-02-16Reiterated RBC Capital Mkts Sector Perform $6 → $5
Nov-05-15Reiterated RBC Capital Mkts Sector Perform $7 → $6
Oct-16-15Reiterated RBC Capital Mkts Sector Perform $8 → $7
Jan-20-11Upgrade RBC Capital Mkts Sector Perform → Outperform $6 → $6
Sep-10-10Initiated RBC Capital Mkts Sector Perform $6
Mar-27-09Upgrade Lazard Capital Mkts Hold → Buy $8
Mar-03-09Reiterated Wedbush Morgan Buy $15 → $9
Mar-03-09Reiterated JMP Securities Mkt Outperform $16 → $9
Jan-05-09Upgrade JP Morgan Underweight → Neutral
Dec-10-08Reiterated Credit Suisse Neutral $11 → $12
Sep-11-08Downgrade JP Morgan Neutral → Underweight
Jun-13-08Downgrade Credit Suisse Outperform → Neutral
May-12-08Reiterated Lehman Brothers Equal-Weight $16 → $12
Apr-22-08Downgrade Wachovia Outperform → Mkt Perform
Apr-11-08Reiterated Credit Suisse Outperform $19 → $16
Mar-10-08Downgrade Susquehanna Financial Positive → Neutral
Mar-06-08Reiterated BMO Capital Markets Market Perform $18 → $14
Mar-05-08Downgrade Lehman Brothers Overweight → Equal-weight $21 → $13
Nov-11-20 10:30PM  
Nov-09-20 02:30PM  
Nov-06-20 05:26PM  
Oct-29-20 08:00AM  
Oct-16-20 05:00AM  
Oct-02-20 08:30AM  
Sep-10-20 08:30AM  
Sep-09-20 08:30AM  
Aug-31-20 09:00AM  
Aug-28-20 08:30AM  
Aug-26-20 09:00AM  
Aug-21-20 03:30PM  
Aug-12-20 08:30AM  
Aug-06-20 04:05PM  
Jul-30-20 08:30AM  
Jun-27-20 02:26PM  
Jun-03-20 11:34PM  
May-21-20 04:05PM  
May-18-20 04:05PM  
May-08-20 09:00AM  
Apr-30-20 08:30AM  
Apr-10-20 11:30AM  
Apr-08-20 10:17PM  
Mar-22-20 09:21AM  
Mar-13-20 09:18PM  
Mar-12-20 12:16PM  
Mar-11-20 04:05PM  
Mar-09-20 04:05PM  
Mar-04-20 08:30AM  
Feb-28-20 08:00AM  
Feb-25-20 08:30AM  
Jan-29-20 11:11AM  
Jan-28-20 11:14AM  
Jan-27-20 10:43AM  
Jan-23-20 09:34AM  
Jan-22-20 10:00AM  
Jan-09-20 04:09PM  
Dec-23-19 11:36AM  
Dec-19-19 08:30AM  
Dec-16-19 08:30AM  
Dec-13-19 08:30AM  
Dec-10-19 07:48PM  
Dec-09-19 08:00AM  
Dec-06-19 11:31AM  
Dec-03-19 09:00AM  
Nov-14-19 08:56AM  
Nov-07-19 11:26AM  
Nov-06-19 04:05PM  
Oct-31-19 02:13PM  
Oct-30-19 09:00AM  
Oct-25-19 07:12AM  
Oct-24-19 10:06PM  
Oct-23-19 07:00AM  
Sep-26-19 09:00AM  
Sep-24-19 10:20AM  
Sep-12-19 10:20PM  
Sep-11-19 10:44PM  
Sep-06-19 09:31AM  
Aug-28-19 07:27AM  
Aug-08-19 11:23AM  
Aug-07-19 04:18PM  
Aug-05-19 04:10PM  
Jul-31-19 09:00AM  
Jul-26-19 01:15PM  
Jun-26-19 07:19AM  
Jun-25-19 04:05PM  
Jun-24-19 09:00AM  
Jun-20-19 07:07PM  
Jun-10-19 04:01PM  
Jun-08-19 09:31AM  
May-30-19 11:02AM  
May-28-19 09:00AM  
May-23-19 01:04PM  
May-22-19 01:33AM  
May-15-19 09:00AM  
May-12-19 06:27PM  
May-10-19 10:51AM  
May-09-19 07:24PM  
May-08-19 10:38AM  
May-07-19 06:00AM  
May-06-19 02:53PM  
May-03-19 03:41PM  
May-02-19 11:44AM  
May-01-19 11:46AM  
Apr-26-19 02:04PM  
PDL BioPharma, Inc. manages various patents in the United States and internationally. The company's patents cover humanization of antibodies. It also offers notes and other long-term receivables services, as well as engages in the equity investment activities. The company was formerly known as Protein Design Labs, Inc. and changed its name to PDL BioPharma, Inc. in 2006. PDL BioPharma, Inc. was founded in 1986 and is headquartered in Incline Village, Nevada.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
GRYSKA DAVID WDirectorNov 23Sale2.4350,000121,500105,337Nov 24 07:25 PM
O'Farrell Elizabeth G.DirectorNov 23Sale2.4425,82663,0150Nov 24 07:25 PM
Bazaar Alan LeeDirectorNov 20Sale2.4233,43581,00310,438Nov 20 08:22 PM
Bazaar Alan LeeDirectorNov 18Option Exercise1.7137,08063,40770,515Nov 20 08:22 PM
GRYSKA DAVID WDirectorNov 18Option Exercise1.6460,00098,400155,337Nov 20 08:22 PM
O'Farrell Elizabeth G.DirectorNov 18Sale2.3863,291150,69625,826Nov 20 08:22 PM
GRYSKA DAVID WDirectorNov 18Sale2.3950,000119,50095,337Nov 19 05:33 PM
GRYSKA DAVID WDirectorNov 17Sale2.40100,000240,000145,337Nov 19 05:33 PM
PDL BIOPHARMA, INC.10% OwnerSep 29Buy11.168,70397,1258,667,397Oct 01 05:52 PM
affiliate | advertise | contact | privacy | help
Do not sell my personal information

Quotes delayed 15 minutes for NASDAQ, and 20 minutes for NYSE and AMEX.
Copyright © 2007-2020 All Rights Reserved.